Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Roman I. Krivochenitser"'
Autor:
Nicholas S. Duesbery, Kyle A. Furge, Barbara E. Kitchell, Debra A. Kamstock, Dafydd G. Thomas, Laurence H. Baker, Michelle J. Dawes, Roe E. Froman, Roman I. Krivochenitser, Elissa A. Boguslawski, Karl J. Dykema, Brian J. Nickoloff, Nicholas J. Andersen
PDF file - 126K, Supplemental Figure S4. Increase in MEF2c IHC staining in AS and HSA primary tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::143fbcfb4486cee3c6590694703420f3
https://doi.org/10.1158/1535-7163.22499599
https://doi.org/10.1158/1535-7163.22499599
Autor:
Nicholas S. Duesbery, Kyle A. Furge, Barbara E. Kitchell, Debra A. Kamstock, Dafydd G. Thomas, Laurence H. Baker, Michelle J. Dawes, Roe E. Froman, Roman I. Krivochenitser, Elissa A. Boguslawski, Karl J. Dykema, Brian J. Nickoloff, Nicholas J. Andersen
PDF file - 142K, Supplemental Figure S2. Reduction of phospho-ERK1/2 IHC staining of cutaneous-derived xenograft and cardiac-derived tumorgraft treated with CI-1040.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c82e05a4a59ab68147b6305169e787f
https://doi.org/10.1158/1535-7163.22499605
https://doi.org/10.1158/1535-7163.22499605
Autor:
Nicholas S. Duesbery, Kyle A. Furge, Barbara E. Kitchell, Debra A. Kamstock, Dafydd G. Thomas, Laurence H. Baker, Michelle J. Dawes, Roe E. Froman, Roman I. Krivochenitser, Elissa A. Boguslawski, Karl J. Dykema, Brian J. Nickoloff, Nicholas J. Andersen
Angiosarcoma is a rare neoplasm of endothelial origin that has limited treatment options and poor five-year survival. As a model for human angiosarcoma, we studied primary cells and tumorgrafts derived from canine hemangiosarcoma (HSA), which is also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc0e69e348ce507dbdc364f9886d903
https://doi.org/10.1158/1535-7163.c.6536191
https://doi.org/10.1158/1535-7163.c.6536191
Autor:
Nicholas S. Duesbery, Kyle A. Furge, Barbara E. Kitchell, Debra A. Kamstock, Dafydd G. Thomas, Laurence H. Baker, Michelle J. Dawes, Roe E. Froman, Roman I. Krivochenitser, Elissa A. Boguslawski, Karl J. Dykema, Brian J. Nickoloff, Nicholas J. Andersen
PDF file - 146K, Supplemental Figure S3. Reduction of phospho-ERK1/2 IHC staining of cutaneous-derived xenograft and cardiac-derived tumorgraft treated with sorafenib.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1647594ac1476a8494eecb7ee78eeaa6
https://doi.org/10.1158/1535-7163.22499602
https://doi.org/10.1158/1535-7163.22499602